Inspire Medical Systems Inc [INSP] is -19.67% lower this YTD. Is it still time to buy?

Inspire Medical Systems Inc [NYSE: INSP] loss -33.47% or -82.22 points to close at $163.41 with a heavy trading volume of 4643696 shares.

The daily chart for INSP points out that the company has recorded -0.56% loss over the past six months.

If we look at the average trading volume of 481.58K shares, INSP reached to a volume of 4643696 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Inspire Medical Systems Inc [INSP]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INSP shares is $253.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INSP stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for Inspire Medical Systems Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May-09-24. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on April 19, 2024, representing the official price target for Inspire Medical Systems Inc stock. Previously, the target price had yet another raise to $250, while Morgan Stanley analysts kept a Overweight rating on INSP stock.

The Average True Range (ATR) for Inspire Medical Systems Inc is set at 15.97, with the Price to Sales ratio for INSP stock in the period of the last 12 months amounting to 7.49. The Price to Book ratio for the last quarter was 8.23, with the Price to Cash per share for the same quarter was set at 14.57. Price to Free Cash Flow for INSP in the course of the last twelve months was 1504.96 with Quick ratio for the last quarter at 7.25.

Trading performance analysis for INSP stock

Inspire Medical Systems Inc [INSP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -33.03. With this latest performance, INSP shares dropped by -31.42% in over the last four-week period, additionally sinking by -0.56% over the last 6 months – not to mention a drop of -42.12% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INSP stock in for the last two-week period is set at 26.14, with the RSI for the last a single of trading hit 18.23, and the three-weeks RSI is set at 32.06 for Inspire Medical Systems Inc [INSP]. The present Moving Average for the last 50 days of trading for this stock 214.91, while it was recorded at 232.18 for the last single week of trading, and 198.85 for the last 200 days.

Inspire Medical Systems Inc [INSP]: A deeper dive into fundamental analysis

Inspire Medical Systems Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.25 and a Current Ratio set at 7.93.

Inspire Medical Systems Inc [INSP]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INSP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Inspire Medical Systems Inc go to 54.10%.

An analysis of Institutional ownership at Inspire Medical Systems Inc [INSP]

The top three institutional holders of INSP stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in INSP stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in INSP stock with ownership which is approximately 5.8386%.

Most Popular